Indegene Stock Market Listing ,The IPO of life science industry giant Indegene has given high returns to investors on its listing even in the market selloff today. However, the huge fall in the market has affected the listing of shares. The company’s stock is listed on BSE at Rs 660 compared to its issue price of Rs 452.Indegene Stock PriceHappened. That means investors have been given a return of 46 percent or Rs 208 per share on listing. The question arises whether investors should book profits after listing or hold on to the shares for further gains.
Top 100 Stocks: These frontline stocks could not beat FD in 3 year returns, many caused losses to investors
Subscribed more than 70 times
Indigene’s IPO was subscribed 70.30 times overall. In this IPO, 35 percent shares were reserved for retail investors and it was subscribed 7.86 times or 786 percent. 50 percent of its shares were reserved for Qualified Institutional Buyers i.e. QIB and it was subscribed 192.72 times. Whereas 15 percent share was reserved for non-institutional investors i.e. NII and it was subscribed 55.91 times overall. The reserved share for employees was filled 6.62 times.
SBI: Big brokerages are crazy about this banking stock, target kept up to Rs 1003 with BUY rating
How is the company’s outlook?
According to brokerage house Reliance Securities, the company is one of the innovative companies in the life sciences industry with over two decades of experience. It has expertise and fit-for-purpose technology in the healthcare sector, with a portfolio of solutions covering all aspects of commercial, medical, regulatory and research and development operations of life sciences companies.
Shivani Nyati, Head of Wealth, Swastika Investmart, says the company has established client relationships with each of the world’s 20 largest biopharmaceutical companies. The company’s financial performance reflects consistent growth over the last three financial years, supported by a strong customer base of 65 active customers as of December 31, 2023. Additionally, the company has a well-developed technology portfolio, which further strengthens its digital capabilities. The company has a strong market position and strong customer base.
IPO of Virat Kohli-Anushka’s investment company will open on May 15, target to raise Rs 1500 crore, check details
How are you financially?
Talking about the financials of Indengine, the company’s revenue, expenditure and PAT in the financial year 2021 were Rs 996.92 crore, Rs 768.25 crore and Rs 149.41 crore. Whereas for the financial year 2022 it was Rs 1690.50 crore, Rs 1417.10 crore and Rs 162.82 crore. Which increased to Rs 2364.10 crore, Rs 2001.05 crore and Rs 266.10 crore in financial year 2023. Whereas in the first 9 months of financial year 2024, it has been Rs 1969.75 crore, Rs 1644.64 crore and Rs 241.90 crore.
(Disclaimer: The advice for investing or selling stocks has been given by experts and brokerage houses. These are not the personal views of Financial Express. There are risks in the market, so take expert opinion before investing.)
